OMB.report

Federal forms, ICRs, and supporting documents

Information Collection

Erythromycin 200 Injectable INAD #12–781 - Private Sector

IC 259417 under ICR 202303-1018-006 · OMB unassigned.

Documents and Forms
Document Name
Document Type
Form and Instruction
Form and Instruction
Form and Instruction
Information Collection (IC) Details

View Information Collection (IC)

Erythromycin 200 Injectable INAD #12–781 - Private Sector
 
No New
 
Required to Obtain or Retain Benefits
 
21 CFR 511 21 CFR 514

Document Type Form No. Form Name Instrument File URL Available Electronically? Can Be Submitted Electronically? Electronic Capability
Form and Instruction ERYMICIN- (W, 1, 2, 3) STUDY PROTOCOL FOR A COMPASSIONATE AQUACULTURE INVESTIGATIONAL NEW ANIMAL DRUG (INAD) EXEMPTION FOR ERYTHROMYCIN (Erymicin 200 Injection) (INAD 12-781) Erymicin study protocol updated Dec 2021.docx Yes Yes Fillable Fileable

Natural Resources Conservation, Marine and Land Management

 

2 0
   
Private Sector Businesses or other for-profits, Farms
 
   100 %

  Approved Program Change Due to New Statute Program Change Due to Agency Discretion Change Due to Adjustment in Agency Estimate Change Due to Potential Violation of the PRA Previously Approved
Annual Number of Responses for this IC 2 0 2 0 0 0
Annual IC Time Burden (Hours) 8 0 8 0 0 0
Annual IC Cost Burden (Dollars) 1,670 0 1,670 0 0 0

Title Document Date Uploaded
No associated records found
            Blank fields in records indicate information that was not collected or not collected electronically prior to July 2006.